A couple of months ago we (Marchant / Stevens) wrote an article on the status of gene patents following the Supreme Court’s June 2013 decision in Association for Molecular Pathology v. Myriad Genetics, Inc. Our paper was recently published by Verlagsgruppe Deutscher Fachverlag, a German establishment which among its specialized publications includes InTeR – Zeitsschrift zum Innovations – und Technikrecht, a quarterly journal devoted to law and innovation. We are pleased to share our contribution with you, available at InTeR Issue #4 December 2013.